Swiss, French booster dose for Hyderabad biz

A month after it opened its integrated R&D and manufacturing facility in Hyderabad’s Genome Valley at an investment of Euro 30 million (approx Rs 250 crore), Swiss biopharma giant Ferring Pharmaceuticals is now gearing up to inject another Euro 60 million (approx. Rs 500 crore) in expanding its Hyderabad facilities over the next two to three years.

from Hyderabad News: Latest Hyderabad News Headlines & Live News Updates from Hyderabad - Times of India https://ift.tt/kacTH62